IRCT201702109014N143已完成2 期
The incidence risk of preeclampsia in pregnant women treated with selenium supplementation versus placebo: a randomized double-blind placebo-controlled trial
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 158 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 158
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •Primigravid; first trimester.
- •Exclusion criteria: Using selenium supplementation during past year; using any medications except ferrous sulfate and folic acid; thyroid disease; diabetes; hypertension; infective diseases; diet full of selenium.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
To assess risk of high BP in pregnant women.CTRI/2020/03/023799Kasturba Medical College Manipal
尚未招募
不适用
Clinical Risk Factors of Preeclampsia in Twin PregnanciesClinical Risk Factors for Preeclampsia in Twin Pregnancies at King Chulalongkorn Memorial HospitalTwins,Pre-ecalmpsia,Pregnancy-induced hypertension,Risk factors,PrevalenceTCTR20190630001Department of Obstetrics and Gynecology, Faculty of Medicine , Chulalongkorn University700
已完成
不适用
Prediction of preeclampsia and adverse eventspreeclampsiatoxemia10026908NL-OMON48757eids Universitair Medisch Centrum400
已完成
不适用
Risico op hart- en vaatziekten in vrouwen met pre-eclampsie in de voorgeschiedenis.NL-OMON21951Isala Klinieken Zwolle350
已完成
1 期
Treating early onset severe preeclampsia with pravastatin: an early phase clinical trialPreeclampsiaReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Antenatal careACTRN12613000268741The Mercy Hospital for Women12